Home > Balance Sheet > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Total Current Liabilities

    Back to Balance Sheet
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

SYNCOM FORMULATIONS (INDIA) Last 5 Year Total Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2017
Total Current Liabilities ₹62 Cr₹109 Cr₹113 Cr₹78 Cr₹59 Cr

What is the latest Total Current Liabilities ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest Total Current Liabilities ratio of SYNCOM FORMULATIONS (INDIA) is ₹62 Cr based on Mar2025 Consolidated results.
Year Total Current Liabilities
Mar2025₹62 Cr
Mar2024₹109 Cr
Mar2023₹113 Cr
Mar2022₹78 Cr
Mar2017₹59 Cr

How is Total Current Liabilities of SYNCOM FORMULATIONS (INDIA) Trending?

Years Total Current Liabilities % Change
Mar2025 ₹62 Cr
-43.19
Mar2024 ₹109 Cr
-3.89
Mar2023 ₹113 Cr
44.60
Mar2022 ₹78 Cr
33.01
Mar2017 ₹59 Cr -

Compare Total Current Liabilities of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,273.7 Cr 4.2% -3.1% -26.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,615.0 Cr 4% -4.9% -2.3% Stock Analytics
DIVIS LABORATORIES ₹159,943.0 Cr 1.1% -9.3% 9.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹133,336.0 Cr -1.3% -3.7% 24% Stock Analytics
CIPLA ₹107,499.0 Cr 1.5% -9.3% -7.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,590.0 Cr 5% -0.1% 3.3% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

4.2%

-3.1%

-26.1%

SENSEX

3.5%

-1.7%

7.8%


You may also like the below Video Courses